Among the available methods for MRD detection in ALL, flow cytometric analysis of abnormal immunophenotypes and polymerase chain reaction (PCR) amplification of antigen-receptor genes are the most ...

Flow cytometry (FCM), next-generation sequencing, (NGS), and polymerase chain reaction (PCR) are the 3 most common methods clinicians use to diagnose minimal residual disease (MRD) in patients with ...

Detection of minimal residual disease (MRD) in follow-up samples from patients with ALL is essential for evaluation of treatment response. We applied multicolor flow cytometry and real-time ...

For such a familiar technique, flow cytometry holds many surprises. It’s more compact, more maneuverable, and more available than ever. Consequently, flow cytometry is interjecting itself where it was ...

No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2004 ASCO Annual Meeting. This abstract does not include a full text component.

Dublin, Dec. 26, 2022 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing Market by Technology (PCR, Flow Cytometry, NGS), Application (Leukemia, Lymphoma, Solid Tumors), End User(Hospitals, ...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Rarity Bioscience AB offers a new approach to oncology research by extending the ...